Wednesday
May082013

Dr. Y. Nakamura's Presentation at ARVO on Retinitis Pigmentosa Drug

The Foundation Fighiting Blindness reported that Dr. Y. Nakamura presented findings on a Japanese glaucoma drug that may have positive long-term effects when used to treat retinitis pigmentosa.

Read the Article: Retinitis Pigmentosa Drug may have Long-Term Positive Effect

Tuesday
May072013

ORSF at ARVO in Seattle This Week

ORSF is at ARVO this week! Stop by our booth and learn more about our upcoming symposium on the Aging Eye and future projects.

Monday
May062013

Remembering Dr. Stephen J. Ryan, Retina Specialist and Former Head of USC's Keck School of Medicine and Doheny Eye Institute

The Los Angeles Times featured a piece on the life and career of Stephen J. Ryan, retina specialist and former head of USC's Keck School of Medicine and Doheny Eye Institute.

Dr. Ryan spent three decades bringing the Keck School and the Doheny Eye Institute to the forefront in fields of medicine and research. He also published "Retina" in 1989, which was considered the definitive text in the opthalmic field. 

Read the Article: Stephen J. Ryan dies at 73; longtime dean of USC medical school

Monday
Apr292013

TEDWeekends: The Incredible Power Of a Single Pair Of Glasses

Tuesday
Apr022013

$6.2 Million NEI Grant Given to Develop New AMD Treatments

Northwestern University is a recent grantee of a $6.2 million grant from the National Eye Institute to develop new treatments for exudative age-related macular degeneration (AMD).

According to AZoNano.com,   

Exudative AMD is the leading cause of blindness among aging Americans, and the global rate of AMD is expected to double in the next decade due to an aging population. The severe vision loss from AMD is caused by the overgrowth of blood vessels between the outer membrane of the eye and the retina. New therapeutic approaches are needed to restore eye function lost to the disease.   

Read the article: Nanomedicine Part of Major Age-Related Macular Degeneration Study

Monday
Apr012013

It's National Public Health Week

Did you know April 1-7 is National Public Health Week? Join the American Public Health Association in learning about key issues facing public health in the US today and what you can do.

APHA states that this week is meant to be the "time to recognize the contributions of public health and highlight issues that are important to improving our nation."

Watch Surgeon General Regina Benjamin talk about National Public Health Week. 

Monday
Mar252013

2013 Symposia Participants' 20-Year Study

Image courtesy of sciencedirect.com

University of Wisconsin School of Medicine and Public Health's Dr. Ronald Klein and Dr. Barbara Klein recently released the findings from a 20-year study called the Beaver Dam Eye Study. The study looked at the aging population and eye health in the community of Beaver Dam, WI.

"The University of Wisconsin School of Medicine and Public Health study showed that significant improvements in the treatment of major eye diseases helped reduce the numbers of people whose vision was impaired by diseases such as diabetic retinopathy and age-related macular degeneration."

Both researchers will be participants at our 2013 symposia in June. We look forward to hearing more about this study from them at the meeting.

Read the article: BD eye study shows health improving

Friday
Mar222013

MIT Neuroscientist Edward Boyden, Ph.D. Wins 2013 Brain Prize

Image courtesy of Dominick Reuter

Exciting news for MIT's Neuroscientist Edward S. Boyden, Ph.D., an NEI grantee. Dr. Boyden received the prestigious award from the Denmark-based Grete Lundbeck European Brain Research Foundation. It is given to individuals and groups who have "influential contributions to brain research."

"This year, Dr. Boyden shares the prize with five other scientists for developing the revolutionary approach known as optogenetics, which allows researchers to control neural activity with flashes of light. The approach relies on channelrhodopsins (ChRs), which are photosensitive proteins that help certain bacteria and algae move toward light. When ChR genes are delivered to neurons, they render them light-responsive, too—except the light triggers electrical currents that can cause the neurons to fire or stop firing."

Read the article: NEI Grantee Edward Boyden Honored with Prestigious Million Euro Brain Prize